XML 56 R29.htm IDEA: XBRL DOCUMENT
v3.24.0.1

STOCK-BASED COMPENSATION (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2023
STOCK-BASED COMPENSATION |
Schedule of stock-based compensation expense | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Years Ended | ​ | Six Months Ended | ​ | Fiscal Year Ended
​ | ​ | December 31, | ​ | December 31, | ​ | December 31, | ​ | June 30,
​ |  | 2023 |  | 2022 |  | 2021 |  | 2021
Restricted stock | ​ | $ | 6,191 | ​ | $ | 4,515 | ​ | $ | 2,006 | ​ | $ | 2,668
Performance stock | ​ | ​ | 2,953 | ​ | ​ | 2,685 | ​ | ​ | 405 | ​ | ​ | 1,317
Stock appreciation rights | ​ | ​ | 533 | ​ | ​ | 1,179 | ​ | ​ | 779 | ​ | ​ | 1,677
Stock options | ​ | ​ | 19 | ​ | ​ | 32 | ​ | ​ | 28 | ​ | ​ | 68
Total stock-based compensation expense | ​ | $ | 9,696 | ​ | $ | 8,411 | ​ | $ | 3,218 | ​ | $ | 5,730
Schedule of valuation assumptions | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Stock Options | ​
​ | ​ | Years Ended | ​ | Six Months Ended | ​ | Fiscal Year Ended | ​
​ | ​ | December 31, | ​ | December 31, | ​ | December 31, | ​ | June 30, | ​
​ | ​ | 2023 | ​ | 2022 | ​ | 2021 |  | 2021 |
Weighted-average expected volatility |  | — | % | — | % | — | % | 39.4 | %
Weighted-average expected life in years |  | — |  | — |  | — |  | 4.4 |
Weighted-average dividend yield |  | — | % | — | % | — | % | 0.9 | %
Weighted-average risk-free interest rate |  | — | % | — | % | — | % | 0.2 | %
​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | SSARs |
​ | ​ | Years Ended | ​ | Six Months Ended | ​ | Fiscal Year Ended | ​
​ | ​ | December 31, | ​ | December 31, | ​ | December 31, | ​ | June 30, | ​
​ | ​ | 2023 | ​ | 2022 | ​ | 2021 | ​ | 2021 |
Weighted-average expected volatility | ​ | — | % | — | % | — | % | 39.2 | %
Weighted-average expected life in years | ​ | — |  | — |  | — |  | 4.2 | ​
Weighted-average dividend yield | ​ | — | % | — | % | — | % | 0.9 | %
Weighted-average risk-free interest rate | ​ | — | % | — | % | — | % | 0.2 | %
Summary of stock options activity | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | ​ |  | ​ | ​ |  | Weighted- |  | ​ | ​
​ | ​ | ​ | ​ | Weighted- | ​ | Average | ​ | ​ | ​
​ | ​ | ​ | ​ | Average | ​ | Remaining | ​ | Aggregate
​ | ​ | Number of | ​ | Exercise | ​ | Contractual | ​ | Intrinsic Value
​ | ​ | Shares | ​ | Price | ​ | Life (Years) | ​ | (in thousands)
Outstanding at January 1, 2023 |  | 17,878 | ​ | $ | 81.17 |  |  |  | ​ |
Exercised |  | (6,534) | ​ | $ | 71.39 |  |  |  | ​ |
Forfeited |  | — | ​ | $ | — |  |  |  | ​ |
Granted |  | — | ​ | $ | — |  |  |  | ​ |
Outstanding at December 31, 2023 |  | 11,344 | ​ | $ | 86.80 |  | 3.4 | ​ | $ | 431
Exercisable at December 31, 2023 |  | 11,344 | ​ | $ | 86.80 |  | 3.4 | ​ | $ | 431
Summary of SSARs activity | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | ​ |  | ​ | ​ |  | Weighted- |  | ​ | ​
​ | ​ | ​ | ​ | Weighted- | ​ | Average | ​ | ​ | ​
​ | ​ | ​ | ​ | Average | ​ | Remaining | ​ | Aggregate
​ | ​ | Number of | ​ | Exercise | ​ | Contractual | ​ | Intrinsic Value
​ | ​ | Shares | ​ | Price | ​ | Life (Years) | ​ | (in thousands)
Outstanding at January 1, 2023 |  | 174,906 | ​ | $ | 111.65 |  |  |  | ​ |
Exercised |  | (17,627) | ​ | $ | 99.34 |  |  |  | ​ |
Forfeited |  | — | ​ | $ | — |  |  |  | ​ |
Granted |  | — | ​ | $ | — |  |  |  | ​ |
Outstanding at December 31, 2023 |  | 157,279 | ​ | $ | 113.03 |  | 5.2 | ​ | $ | 2,526
Exercisable at December 31, 2023 |  | 157,279 | ​ | $ | 113.03 |  | 5.2 | ​ | $ | 2,526
Summary of non-vested awards | ​
​ | ​ | ​ | ​ | ​ | ​
​ |  | ​ |  | Weighted-
​ | ​ | ​ | ​ | Average
​ | ​ | Number of | ​ | Grant Date
​ | ​ | Shares | ​ | Fair Value
Outstanding at January 1, 2023 |  | 166,441 | ​ | $ | 122.05
Granted |  | 82,740 | ​ | $ | 139.50
Exercised |  | (5,847) | ​ | $ | 82.30
Non-attainment |  | (27,143) | ​ | $ | 79.84
Forfeited |  | — | ​ | $ | —
Outstanding at December 31, 2023 |  | 216,191 | ​ | $ | 135.11
Summary of the status of non-vested restricted stock | ​
​ | ​ | ​ | ​ | ​ | ​
​ |  | ​ |  | Weighted-
​ | ​ | ​ | ​ | Average
​ | ​ | Number of | ​ | Grant Date
​ | ​ | Shares | ​ | Fair Value
Outstanding at January 1, 2023 |  | 120,542 | ​ | $ | 116.76
Granted |  | 56,710 | ​ | $ | 120.67
Vested |  | (41,139) | ​ | $ | 115.24
Forfeited |  | — | ​ | $ | —
Exercised | ​ | — | ​ | $ | —
Outstanding at December 31, 2023 |  | 136,113 | ​ | $ | 118.84

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options and stock appreciation rights (SARs), including, but not limited to: (a) expected term of share options, SARs and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References No definition available. + Details
Name: | rgld_ScheduleOfShareBasedPaymentAwardStockOptionsAndStockAppreciationRightsValuationAssumptionsTableTextBlock
Namespace Prefix: | rgld_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the changes in outstanding nonvested shares. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for stock appreciation rights awards that were outstanding at the beginning and end of the year, and the number of stock appreciation rights awards that were granted, exercised or converted, forfeited, and expired during the year. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year. + References No definition available. + Details
Name: | us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration